Related Experiment Video
Updated: Apr 23, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.1K
[Psoriasis as metabolic and cardiovascular risk factor]
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|September 26, 2014
Summary
Psoriasis patients have higher rates of metabolic issues and cardiovascular disease risk. Early screening for metabolic disturbances is crucial for managing psoriasis and preventing heart problems.
Area of Science:
- Dermatology
- Cardiology
- Endocrinology
Context:
- Psoriasis is a chronic inflammatory disease with a high recurrence rate.
- Patients with psoriasis exhibit a higher prevalence of metabolic disturbances compared to the general population.
- Systemic inflammation in psoriasis contributes to an increased risk of cardiovascular diseases.
Purpose:
- To highlight the increased prevalence of metabolic disturbances in psoriasis patients.
- To emphasize the elevated cardiovascular disease risk associated with psoriasis.
- To advocate for routine metabolic screening in individuals with psoriasis and psoriatic arthritis.
Summary:
- Psoriasis is linked to more frequent metabolic disturbances.
- The inflammatory nature of psoriasis elevates cardiovascular disease risk.
- Screening for metabolic issues is recommended for all psoriasis patients.
Impact:
- Early detection and management of metabolic disturbances can mitigate cardiovascular risks in psoriasis patients.
- Enhanced patient care through integrated screening protocols.
- Improved long-term health outcomes for individuals with psoriasis.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:27Psychoneuroimmunology: Cardiovascular Disease
751
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
751
01:24Overview of Lipid Metabolism
6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K
01:30Atherosclerosis I: Introduction
2.3K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.3K
01:26Atherosclerosis III: Management
634
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
01:26Type I Diabetes II: Pathophysiology
42
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
42